Open access · OA
via Europe PMC
Multi-omics identification of novel biomarkers and therapeutic targets for Parkinson's disease: from transcriptome to drug interaction
Frontiers in aging neuroscience
Abstract
This study in Frontiers in aging neuroscience examines multi-omics data to identify potential biomarkers and therapeutic targets for Parkinson's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
B, Z., Z, S., X, P., & Y., Q. (n.d.). Multi-omics identification of novel biomarkers and therapeutic targets for Parkinson's disease: from transcriptome to drug interaction. <em>Frontiers in aging neuroscience</em>. https://europepmc.org/article/PMC/PMC13638360
Vancouver
B Z, Z S, X P, Y. Q. Multi-omics identification of novel biomarkers and therapeutic targets for Parkinson's disease: from transcriptome to drug interaction. Frontiers in aging neuroscience.
BibTeX
@article{zhaondMultio,
title = {Multi-omics identification of novel biomarkers and therapeutic targets for Parkinson's disease: from transcriptome to drug interaction},
author = {Zhao B and Shi Z and Pang X and Qi Y.},
journal = {Frontiers in aging neuroscience},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Drug Discovery Today 2023
Citation only
Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson’s Disease
The Lancet 2009
Citation only
Parkinson's disease
The Lancet 2021
Open access · OA
Parkinson's disease
Neurochemistry International 2013
Citation only
Biomarkers in Parkinson’s disease (recent update)
Pharmacological Research 2008
Preprint · OA
α-Synuclein: A therapeutic target for Parkinson’s disease?
Journal of Parkinson's disease : Duplicate, marked for deletion 2026
Open access · OA